EG
DXCM icon

Ellerson Group’s DexCom DXCM Stock Holding History

Ellerson Group’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.6M Sell
53,380
-20
-0% -$1.33K 2.12% 20
2026
Q1 		$3.35M Sell
53,400
-3
-0% -$209 2.2% 19
2025
Q4 		$3.54M Sell
53,403
-15,044
-22% -$973K 2.4% 19
2025
Q3 		$4.61M Sell
68,447
-25
-0% -$1.98K 2.87% 8
2025
Q2 		$5.98M Sell
68,472
-1,410
-2% -$111K 4.21% 5
2025
Q1 		$4.77M Sell
69,882
-153
-0.2% -$12.5K 3.79% 5
2024
Q4 		$5.45M Buy
70,035
+15,722
+29% +$1.16M 3.97% 4
2024
Q3 		$3.64M Sell
54,313
-14,863
-21% -$1.22M 2.86% 14
2024
Q2 		$7.84M Buy
69,176
+6,928
+11% +$876K 5.97% 3
2024
Q1 		$8.63M Sell
62,248
-2,320
-4% -$292K 6.6% 2
2023
Q4 		$8.01M Hold
64,568
– – 6.95% 3
2023
Q3 		$6.02M Buy
64,568
+65
+0.1% +$7.33K 5.61% 3
2023
Q2 		$8.29M Sell
64,503
-2,434
-4% -$294K 7.89% 3
2023
Q1 		$7.78M Sell
66,937
-111
-0.2% -$12.4K 8.43% 2
2022
Q4 		$7.59M Buy
+67,048
New +$7.36M 8.04% 1

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Ellerson Group's DXCM Position: Q2 2026 in Review

Ellerson Group reduced its DexCom (DXCM) stake by 0.04% in Q2 2026, selling an estimated $1.33K and leaving 53,380 shares worth $3.6M. The position accounts for 2.12% of the portfolio, ranked #20.

Ellerson Group first reported a position in DXCM in Q4 2022 and has held it in 15 quarters since. The position peaked at $8.63M in Q1 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Ellerson Group held 53,380 shares of DexCom worth $3.6M as of Q2 2026.
  • Ellerson Group sold 20 DexCom shares in Q2 2026, an estimated $1.33K.
  • DexCom made up 2.12% of Ellerson Group's portfolio in Q2 2026, its #20 holding.
  • Ellerson Group first reported a position in DexCom in Q4 2022 and has held it in 15 quarters since.
  • Ellerson Group's DexCom position peaked at $8.63M in Q1 2024.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Ellerson Group's 13F filing for Q2 2026, filed 31 Jul 2026.